ShiSi Pharmaceutical Group (02005.HK) obtains the drug production registration certificate for Rosuvastatin Ezetimibe Tablets (I) (10mg) from the National Medical Products Administration.

China Fortune Financial APP News, Sino Biopharmaceutical Group (02005.HK) announced that the Group has obtained the drug production registration certificate for Rosuvastatin Calcium Tablets (I) (10mg) from the China National Medical Products Administration, classified as a class 4 chemical drug and deemed to have passed consistency evaluation. This makes the Group the third domestic company to receive such approval.